Medose Pharmaceuticals Private Limited

Medose Pharmaceuticals Private Limited - chemicals in Bangalore, Karnataka, India. Directors, charges & compliance details.
CIN U24290KA2020PTC140244 Incorporated 26 October 2020 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company chemicals MSME · Micro
Data last updated
Revenue · FY 2023
₹3.68 Cr
▲ 3% YoY
Net profit · FY 2023
₹3.32 Lakh
Net margin 0.9%
EBITDA · FY 2023
₹4.33 Lakh
EBITDA margin 1.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹3.29 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Medose Pharmaceuticals Private Limited

Data last updated:

Medose Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 26 October 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24290KA2020PTC140244. Its GSTIN is 08AANCM9573G1ZT (Rajasthan).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3.29 Lakh. It is led by directors Sunil Sharma and Umesh Saraswat.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat No. 402 Block C Habitat Irenic Choodasandra Kasavanhalli, Bangalore, Karnataka, India – 560035.

As per the financials filed for FY 2023, the company reported a revenue of ₹3.68 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹3.32 Lakh (net margin 0.9%) and EBITDA of ₹4.33 Lakh (EBITDA margin 1.2%).

Court records list 1 case involving the company, including 1 filed against it.

Medose Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0058181). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24290KA2020PTC140244
Registration Number 140244
Incorporation Date 26 October 2020
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-RJ-17-0058181

Recognitions & Rankings of Medose Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2020-21)
Udyam number
UDYAM-RJ-17-0058181

Contact details

Medose Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka.

  • Registered Address
    Flat No. 402 Block C Habitat Irenic Choodasandra Kasavanhalli, Bangalore, Karnataka, India – 560035
  • Industry
    Chemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Medose Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Medose Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Medose Pharmaceuticals Private Limited, buy the company report.

Financials of Medose Pharmaceuticals Private Limited

FY 2024 filings available

Medose Pharmaceuticals Private Limited reported revenue of ₹3.68 Cr (up 3% YoY) for FY 2023.

Revenue · FY 2023
₹3.68 Cr ▲ 3%
Net profit · FY 2023
₹3.32 Lakh margin 0.9%
EBITDA · FY 2023
₹4.33 Lakh margin 1.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 3%
EBITDA CAGR growth
1 year
▲ 39%

Revenue rose 3% in the latest year. EBITDA rose 39% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.33 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3.32 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin1.2%
Net Profit Margin0.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Medose Pharmaceuticals Private Limited, buy the company report.

Board of directors of Medose Pharmaceuticals Private Limited

Medose Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sunil SharmaDirector26 Oct 20206 Years 0 MonthsCurrent
Umesh SaraswatDirector26 Oct 20206 Years 0 MonthsCurrent

Peer comparison

Medose Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Fierce One Pharmaceuticals Private Limited₹3.72 Cr (FY 2024)-20.0%Roorkee, Uttarakhand, India
Konsyl Pharmaceuticals Private Limited₹3.68 Cr (FY 2024)35.0%Sanand, Gujarat, India
Medose Pharmaceuticals Private Limitedthis company₹3.68 Cr (FY 2023)₹3.32 Lakh0.9%3.0%Bangalore, Karnataka, India
Mericana Pharmaceuticals Private Limited₹3.65 Cr (FY 2025)-43.0%Indore, Madhya Pradesh, India
Success Pharmaceuticals Private Limited₹3.63 Cr (FY 2025)-3.0%Prayagraj, Uttar Pradesh, India

To see the full peer comparison of Medose Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Medose Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Medose Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
08AANCM9573G1ZTRajasthanActive22 Mar 2021

To see the full GST registrations and return filing status of Medose Pharmaceuticals Private Limited, buy the company report.

Recent activity

Medose Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Sunil Sharma was appointed as Director on 26 Oct 2020.

AGM
Medose Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Medose Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
Appointed
Sunil Sharma was appointed as Director.
Appointed
Umesh Saraswat was appointed as Director.
Incorporation
26 Oct 2020
Medose Pharmaceuticals Private Limited was registered on 26 Oct 2020 with Roc Bangalore & aged 6 years 6 days as per MCA records.

Frequently asked questions

Medose Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 26 October 2020 (6+ years old) and is registered under CIN U24290KA2020PTC140244.

Medose Pharmaceuticals has 2 current directors:

The latest financial statements of Medose Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Medose Pharmaceuticals is 08AANCM9573G1ZT, registered in Rajasthan.

The CIN (Corporate Identification Number) of Medose Pharmaceuticals is U24290KA2020PTC140244. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Medose Pharmaceuticals has 1 court case on record: 1 filed against it.

Medose Pharmaceuticals was incorporated on 26 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.

The peers of Medose Pharmaceuticals by revenue are Fierce One Pharmaceuticals Private Limited, Konsyl Pharmaceuticals Private Limited, Mericana Pharmaceuticals Private Limited, Success Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Sunil Sharma was appointed as Director on 26 Oct 2020. Umesh Saraswat was appointed as Director on 26 Oct 2020.

Yes, Medose Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0058181).

The registered office of Medose Pharmaceuticals is at Flat No. 402 Block C Habitat Irenic Choodasandra Kasavanhalli, Bangalore, Karnataka, India – 560035.